Fox Chase Cancer Center News

PHILADELPHIA (November 8, 2021)—In Vino Vita, Fox Chase Cancer Center’s signature fundraising event, was held on October 30 at the National Constitution Center, and raised over $1.5 million for cancer research, treatment and prevention.

PHILADELPHIA (November 4, 2021)—As more radiographic, histopathologic, and genomic data are gathered and made accessible, it is only a matter of time until artificial intelligence (AI) becomes part of the regular clinical workflow for treating kidney cancer, according to a review article published by researchers at Fox Chase Cancer Center.

PHILADELPHIA (November 3, 2021)—Benjamin A. Young, CCRP, has been appointed Program Manager at the Marvin & Concetta Greenberg Pancreatic Cancer Institute, where he will work with researchers to coordinate the institute’s basic, clinical, and population sciences research programs.

PHILADELPHIA (November 2, 2021)—Marcin Chwistek, MD, FAAHPM, director of the Supportive Oncology and Palliative Care Program at Fox Chase Cancer Center, will be speaking virtually at the Hospice Care Professionals Association Conference being held in Moscow November 2-3.

PHILADELPHIA (October 25, 2021)—A multi-institutional retrospective analysis conducted by researchers at Fox Chase Cancer Center has found that early stage prostate cancer patients treated with moderately hypofractionated intensity-modulated radiation therapy or proton beam radiation therapy had low risk of serious late genitourinary and gastrointestinal complications.

PHILADELPHIA (October 24, 2021)—In a recent retrospective study, researchers at Fox Chase Cancer Center found anorectal cancer patients reirradiated with pulsed low-dose-rate radiotherapy had reduced toxicity and improved outcomes when compared with patients treated with twice-daily radiotherapy.

PHILADELPHIA (October 19, 2021)—Fox Chase Cancer Center’s Edna “Eti” Cukierman, PhD, co-director of the Marvin & Concetta Greenberg Pancreatic Cancer Institute, has been named a senior editor for Cancer Research Communications, a new online journal.  

PHILADELPHIA (October 15, 2021)—Recent findings from a study conducted at Fox Chase Cancer Center could help pave the way for more effective treatment of aggressive brain tumors, researchers say.